LCN2 and acute kidney injury: Furthermore, Lcn-2 is considered a real-time, sensitive biomarker for renal diseases and not only plays a role as a biomarker for disease states, but in certain cases, also actively protects against acute kidney injury (AKI), such as ischemia–reperfusion injury [72].